This chapter deals with those issues not well ascribed to a particular organ system or single diagnosis. The first section will focus on nonimmune hydrops, a nonspecific finding occurring as a common final pathway due to a multitude of reasons, many of which carry a grave prognosis, the minority of which are amenable to therapeutic intervention. The second section will focus on the effect of maternal substance use on the fetus and newborn. Both licit and illicit drug use will be described as both have implications for fetal and newborn well-being.
Hydrops Fetalis
Hydrops fetalis was first described by Ballantyne over 110 years ago, and over 60 years later by Potter, who described nonimmune hydrops. Hydrops is defined by the presence of fluid accumulation in the fetal extravascular space and body cavities. It is characterized by greater than 5 mm of generalized skin thickening, with associated pericardial or pleural effusions, ascites, or placental enlargement. While in the 1970s over...
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Agthe AG, Kim GR, Mathias KB, Hendrix CW, Chavez-Valdez R, Jansson L et al (2009) Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Pediatrics 123(5):e849–e856
American College of Obstetricians and Gynecologists (2007) ACOG Practice Bulletin No 86: Viral hepatitis in pregnancy. Obstet Gynecol Oct 110(4):941–956
American College of Obstetricians and Gynecologists (July 1998) ACOG Educational Bulletin No 248: Viral hepatitis in pregnancy. Int J Gynaecol Obstet 63:195–202
Anandakumar C, Biswas A, Wong YC, Chia D, Annapoorna S, Ratnam S (1996) Management of non-immune hydrops: 8 years’ experience. Ultrasound Obstet Gynecol 8:196–200
Aubard Y, Derouineau V, Aubard V, Chalifour V, Preux PM (1998) Primary fetal hydrothorax: a literature review and proposed antenatal clinical strategy. Fetal Diagn Ther 13:325–333
Bauer CR, Langer JC, Shankaran S, Bada HS, Lester B, Wright LL et al (2005) Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med 159:824–834
Bell J (2006) National Working Group. National clinical guidelines for the management of drug use during pregnancy, birth and the early development years of the newborn. International Governmental Committee on Illicit Drugs, Canberra
Bellini C, Hennekan RCM, Fulcheri E, Rutigliani M, Morcaldi G, Boccardo F, Bonioli E (2009) Etiology of non-immune hydrops fetalis: a systematic review. Am J Med Genet A 149A:844–851
Bennett D, Bendersky M, Lewis M (2008) Children’s ability from 4 to 9 years old as a function of prenatal cocaine exposure, environmental risk, and maternal verbal intelligence. Develop Psychol 44(4):919–928
Bhuvaneswar CG, Chang G, Epstein LA, Stern TA (2008) Cocaine and opioid use during pregnancy: prevalence and management. Prim Care Companion. J Clin Psychiatr 10(1):59–65
Brunnemann K, Hoffman D (1991) Analytical studies on tobacco specific N nitrosamines in tobacco and tobacco smoke. Crit Rev Toxicol 21:235–240
Buka SL, Shenassa ED, Niaura R (2003) Elevated Risk of Tobacco Dependence Among Offspring of Mothers Who Smoked During Pregnancy: A 30-Year Prospective Study. Am J Psychiatry 160:1978–1984
CDC Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease (1998) MMWR Oct 16. 47(RR19);1–39
CDC. Sociodemographic and behavioral characteristics associated with alcohol consumption during pregnancy-United States, 1998 (1995) MMWR Morb Mortal Wkly Rep. 44:261–264
Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA (2006) Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn. N Engl J Med 354:579–587
Chan D, Klein J, Koren G (2003) New Methods for Neonatal Drug screening. NeoReviews 4(9):e236–e244
Chang L, Smith LM, Lopresti C (2004) Smaller subcortical volumes and cognitive deficits on children with prenatal methamphetamine exposure. Psychiatry Res 132:95–106
Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC (Feb. 1 2006) Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295(5):499–507
Colliver JD, Kroutil LA, Dai L, Gfroerer JC (2006) Misuse of prescription drugs: data from the 2002, 2003, and 2004 national surveys on Drug Use and Health (DHHS Publication No. SMA 06-4192, Analytic Series A-28). Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD
Coyle MG, Ferguson A, Lagasse L, Oh W, Lester B (2002) Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants. J Pediatr 140:561–564
Dashe J, Jackson GL, Olscher DA, Zane EH, Wendel GD (1998) Opioid detoxification in pregnancy. Obstet Gynecol 92(5):854–858
English DR, Hulse GK, Milne E, Holman ME, Bower CL (1997) Maternal cannabis use and birth weight: a meta-analysis. Addiction 92:1553–1560
Finnegan L, Connaughton J, Kron R, Emich J (1975) Neonatal abstinence syndrome: assessment and management. Addict Dis 2:141–158
Fried PA, Watkinson B (2000) Visuoperceptual functioning differs in 9 to 12-year-olds prenatally exposed to cigarettes and marijuana. Neurotoxicol Teratol 22:11–20
Goldschmidt L, Day NL, Richardson GA (2000) Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol 22:325–336
Haddad PM, Pal BR, Clarke P, Wieck A, Sridhiran S (Sept. 2005) Neonatal symptoms following maternal paroxitine treatment: Serotonin toxicity or paroxitine discontinuation syndrome? J Psychopharm 19(5):554–557
Hofstaetter C, Gudmundsson S (2010) Venous Doppler in the evaluation of fetal hydrops. Obstet Gynecol Internat ID 430157, 7
Jansson LM, Velez M, Harrow C (2009) The opioid exposed newborn: assessment and pharmacologic management. J Opioid Manag 5(1):47–55
Jones HE, Kaltenbach K, Heil S, Stine SM, Coyle MG, Arria AM, O’Grady K, Selby P, Martin P, Fischer G (2010) Neonatal abstinence syndrome following methadone or buprenorphine exposure. N Engl J Med 363:2320–2331
Law KL, Stroud LR, LaGasse LL, Niaura R, Liu J, Lester BM (2003) Smoking during pregnancy and newborn neurobehavior. Pediatr 111:1318–1323
Lejeune C, Simmat-Durand L, Gourarier L, Aubisson S (2006) Prospective multicenter observational study of 250 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenorphine substitution. Drug Alcohol Depend 82(3):250–257
Lester BM, Tronick EZ, LaGasse L, Seifer R, Bauer CR, Shankaran S, Bada HS, Wright LL, Smeriglio VL, Lu J, Finnegan LP, Maza PL (2002) The maternal lifestyle study: Effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 110:1182–1192
Lewis MW, Misra S, Johnson HL, Rosen TS (2004) Neurological and developmental outcomes of prenatally cocaine-exposed offspring from 12 to 36 months. Amer J Drug Alcoh Abuse 30(2):299–320
Liao C, Wei J, Li Q, Li J, Li L, Li D (2007) Nonimmune hydrops fetalis diagnosed during the second half of pregnancy in southern china. Fetal Diag Ther 22(4):302–305
Lumley J, Chamberlain C, Dowswell T, Oliver S, Oakley L, Watson L (2009) Interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews. Issue 3 Art. No. CD001055
Machin GA (1989) Hydrops revisited: literature review of 1414 cases published in the 1980’s. Am J Med Genet 34:366–390
Mari G, Deter R, Carpenter RL, Rahman F, Zimmerman R, Moise KJ et al (2000) Noninvasive diagnosis by Doppler untrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative group for Doppler assessment of the blood velocity in anemic fetuses. N Engl J Med 342:9–14
McCoy MC, Katz VL, Gould N, Kuller JA (1995) Non-immune hydrops after 20 weeks’ gestation: review of 10 years’ experience with suggestions for management. Obstet Gynecol 85:578–582
Messinger DS, Bauer CR, Das A, Seifer R, Lester BM, LaGasse LL, Wright LL et al (2004) The maternal lifestyle study: cognitive, motor and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatr 113:1677–1685
Morrow CE, Vogel AL, Anthony JC, Ofir AY, Dausa AT, Bandstra ES (2004) Expressive and receptive language functioning in preschool children with prenatal cocaine exposure. J Pediatr Psychol 29(7):543–554
Osborn DA, Cole MJ, Jeffrey HE (2010) Opiate treatment for opiate withdrawal in newborn infants. (Review) Cochrane Database of Systematic Reviews 2010, Issue 10. Art. No.: CD002059. DOI: 10.1002/14651858.CD002059.pub3
Ostrea EM, Brady M, Gause S, Raymondo AL, Stevens M (1992) Drug screening on newborns by meconium analysis: a large scale prospective epidemiologic study. Pediatr 89:107–113
Potter E (1943) Universal edema of the fetus unassociated with erythroblastosis. Am J Obstet Gynecol 46:130–134
Prontera W, Jarggi ET, Pfizenmaier M, Tassaux D, Pfister RE (2002) Ex utero intrapartum treatment (EXIT) of severe hydrothorax. Arch Dis Child Fetal Neonatal Ed 86:F58–F60
Richardson GA, Goldschmidt L, Larkby C (2007) Effects of prenatal cocaine exposure on growth: a longitudinal analysis. Pediatrics 120(4):e1017–e1027
Richardson GA, Ryan C, Willford J (2002) Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol 24:309–320
Sampath V, Narendran V, Donovan EF, Stanek J, Schleiss MR (2005) Nonimmune hydrops fetalis and fulminant fatal disease due to congenital cytomegalovirus infection in a premature infant. J Perinatol 25:608–611
Schydlower M, Anglin TM et al (1995) American Academy of Pediatrics Committee on Substance Abuse. Drug-exposed infants Pediatrics 96(2 Pt 1):364–367
Shankaran S, Lester BM, Das A, Bauer CR, Bada HS, LaGasse L, Higgins R (2007) Impact of maternal substance use during pregnancy on childhood outcome. Semin Fetal Neonatal Med 12(2):143–150
Sidhu JS, Floyd RL (2002) Alcohol consumption among pregnant and child-bearing-aged women-United States, 1991. MMWR Morb Mortal Wkly Rep 46:346–350
Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A et al (2006) The infant development, environment and lifestyle study: Effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 118:1149–1156
Smith LM, LaGasse LL, Derauf C, Grant P, Shah R, Arria A et al (2008) Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol 30(1):20–28
Sokol RJ, Delaney-Black V, Nordstrom B (2003) Fetal alcohol spectrum disorder. JAMA 290:2996–2999
Sood B, Delaney-Black V, Covington C, Nordstrom-Klee B, Ager J, Templin T, Janisse J, Martier S, Sokol RJ (2001) Prenatal alcohol exposure and childhood behavior at 6-7 years: 1. dose-response effect. Pediatrics 108:E34
Stratton K, Howe C, Battaglia F (eds) (1996) Fetal alcohol syndrome: diagnosis, epidemiology, prevention, and treatment. National Academy Press, Washington, DC
Stepan H, Faber R (2006) Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Eng J Med 354:1857–1858
Stephenson T, Zuccollo J, Mohajer M (1994) Diagnosis and management of non-immune hydrops in the newborn. Arch Dis Child 70:F151–F154
Suwanrath-Kengpol C, Kor-anantakul O, Suntharasaj T, Leetanaporn R (2005) Etiology and outcome of non-immune hydrops fetalis in southern Thailand. Gynecol Obstet Investig 59(3):134–137
Velez ML, Montoya ID, Jansson LM, Walters V, Svikis D, Jones HE et al (2006) Exposure to violence among substance-dependent pregnant women and their children. J Subst Abuse Treat 30(1):31–38
Vandevenne M, Vandenbussche H, Verstraete A (2005) Detection time of drugs of abuse in urine. Acta Clin Belg 55:323–333
Vidaeff AC, Pschirrer ER, Mastrobattista JM, Gilstrap LC, Ramin SM (2002) Mirror syndrome. A case report. J Reprod Med 47(9):770–774
Wieacker P, Muschke P, Pollak KH, Muller R (2005) Autosomal recessive non-immune hydrops fetalis caused by systemic lymphangiectasia. Am J Med Gen 132A:318–319
World Drug Report, 2010. Available from: www.unodc.org. Accessed 15 March 2011
Wouldes T, LaGasse L, Sheridan J, Lester B (2004) Maternal methamphetamine use during pregnancy and child outcome: what do we know? J New Zealand Med Assoc 117(1206):U1180
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Coyle, M.G. (2012). Miscellaneous Chapter. In: Elzouki, A.Y., Harfi, H.A., Nazer, H.M., Stapleton, F.B., Oh, W., Whitley, R.J. (eds) Textbook of Clinical Pediatrics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02202-9_34
Download citation
DOI: https://doi.org/10.1007/978-3-642-02202-9_34
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02201-2
Online ISBN: 978-3-642-02202-9
eBook Packages: MedicineReference Module Medicine